Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Coronavirus Update:What patients and families need to know

The Children's National Research Institute

Research Profile

Research Interests

  • Pediatric Oncology
  • Cancer
  • Immunotherapy
  • Adoptive Cell Therapy
  • High-Risk Malignancies
  • Solid Tumors

Education & Training

  • Fellowship, Pediatric Hematology/Oncology, Children's National Hospital, Washington DC (2015-2018) 
  • Residency, Pediatrics, University of Arizona, Tuscon, AZ (2012-2015)
  • M.D., Medicine, Ross University School of Medicine, Porstmouth, Dominica (2008-2012) 
  • B.S., Chemical Biology, University of California, Berkeley, CA (2002-2006)

Academic Appointments

  • Associate Professor of Pediatrics, George Washington University School of Medicine and Health Sciences


Amy Hont, M.D., is an attending physician in the Department of Hematology/Oncology and physician-scientist in the Center for Cancer and Immunology Research. Her research interest focuses on the use of targeted therapies, including immunotherapy, for patients with high-risk malignancies. In particular she investigates the optimization of adoptive cell therapy for patients with relapsed or refractory solid tumor, including modification of T cell products and the tumor microenvironment. 

Research & Publications